Fig. 1From: Diagnostic accuracy and clinical usefulness of erythrocyte creatine content to predict the improvement of anaemia in patients receiving maintenance haemodialysisStudy protocol The dose of erythropoiesis stimulating agent (ESA) was fixed 3Â months prior to the enrollment and was maintained throughout 6Â months period. Laboratory tests were performed at baseline and haemoglobin was measured 3Â months laterBack to article page